Alcohol Use Is Associated With Hepatic Steatosis Among Persons With Presumed Nonalcoholic Fatty Liver Disease
- PMID: 31734449
- PMCID: PMC7569606
- DOI: 10.1016/j.cgh.2019.11.022
Alcohol Use Is Associated With Hepatic Steatosis Among Persons With Presumed Nonalcoholic Fatty Liver Disease
Abstract
Background & aims: Many individuals presumed to have nonalcoholic fatty liver disease (NAFLD) consume moderate amounts of alcohol. Little is known about patterns of alcohol use in patients with NAFLD or how drinking behaviors affect liver fat.
Methods: We conducted a cross-sectional study of 2475 participants of the Framingham Heart Study with hepatic steatosis, as determined by computed tomography. We performed multivariable-adjusted logistic regression models to evaluate the association between alcohol drinking patterns and hepatic steatosis. Models were adjusted for sociodemographic factors, diet, and the components of the metabolic syndrome. We excluded heavy alcohol users, defined as women who consume more than 14 alcohol drinks per week and men who consume more than 21 alcohol drinks per week.
Results: In our sample (mean age, 49.8 ± 10.2 y; 50.3% women), the prevalence of hepatic steatosis was 17.5%. The total number of alcohol drinks per week and the maximum drinks consumed per drinking day each were associated with hepatic steatosis (adjusted odds ratio [aOR], 1.15; 95% CI, 1.02-1.29 and aOR 1.15; 95% CI, 1.02-1.30). Binge drinking occurred in 25.4% of individuals with presumed NAFLD and was associated with an increased odds of hepatic steatosis (aOR, 1.45; 95% CI, 1.06-1.98) among alcohol users. In a beverage-specific analysis, alcohol use patterns were associated with hepatic steatosis among beer drinkers, but not among wine drinkers.
Conclusions: In a cross-sectional study of participants of the Framingham Heart Study with hepatic steatosis, we observed an association between alcohol use and liver fat, even after excluding heavy alcohol users from our analysis. Alcohol use therefore appears to be a risk factor for NAFLD. Prospective studies are needed to validate these findings and determine if alcohol use should be a focus for research, prevention, and treatment of presumed NAFLD.
Keywords: CT; Epidemiology; Lifestyle Factor; Social.
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflicts of interest
The authors disclose no conflicts.
Figures
Comment in
-
Alcohol Use Patterns and Liver Outcomes: Is There Really a Difference Between Drinking Beer and Drinking Wine?Clin Gastroenterol Hepatol. 2020 Jun;18(7):1650-1651. doi: 10.1016/j.cgh.2019.12.018. Epub 2019 Dec 27. Clin Gastroenterol Hepatol. 2020. PMID: 31887441 No abstract available.
-
Reply.Clin Gastroenterol Hepatol. 2020 Jun;18(7):1651-1652. doi: 10.1016/j.cgh.2020.01.001. Epub 2020 Jan 8. Clin Gastroenterol Hepatol. 2020. PMID: 31926338 Free PMC article. No abstract available.
-
Alcohol Use in Patients With NAFLD.Clin Gastroenterol Hepatol. 2021 Jul;19(7):1506. doi: 10.1016/j.cgh.2020.08.004. Epub 2020 Nov 26. Clin Gastroenterol Hepatol. 2021. PMID: 33248071 No abstract available.
-
Reply.Clin Gastroenterol Hepatol. 2021 Jul;19(7):1506-1507. doi: 10.1016/j.cgh.2020.08.058. Epub 2020 Nov 26. Clin Gastroenterol Hepatol. 2021. PMID: 33248106 No abstract available.
References
-
- Younossi ZM. Non-alcoholic fatty liver disease - a global public health perspective. J Hepatol 2019;70:531–544. - PubMed
-
- Kwon HK, Greenson JK, Conjeevaram HS. Effect of lifetime alcohol consumption on the histological severity of non-alcoholic fatty liver disease. Liver Int 2014;34:129–135. - PubMed
-
- Mitchell T, Jeffrey GP, de Boer B, et al. Type and pattern of alcohol consumption is associated with liver fibrosis in patients with non-alcoholic fatty liver disease. Am J Gastroenterol 2018; 113:1484–1493. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
